CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation
Background: Heart transplantation is an emergency surgery requiring cardio-pulmonary bypass (CPB) and its timing is unpredictable. Patients on the transplant waiting list often have multiple reasons for being anticoagulated. Intraoperative removal of apixaban using CytoSorb seems to be an interestin...
Saved in:
Main Authors: | Anouk Frering, MD, Antoine Abi Lutfallah, MD, Aude Carillion, MD, PhD, Daniel Wendt, MD, Pascal Leprince, MD, PhD, Adrien Bougle, MD, PhD, Guillaume Lebreton, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | JHLT Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2950133424001149 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
To Hemoadsorb or Not to Hemoadsorb—Do We Have the Answer Yet? An Updated Meta-Analysis on the Use of CytoSorb in Sepsis and Septic Shock
by: Carmen Orban, et al.
Published: (2025-01-01) -
Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry
by: Michael Schmoeckel, et al.
Published: (2025-01-01) -
Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial
by: Lorenz Weidhase, et al.
Published: (2025-01-01) -
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
by: Alice-Christin Acevedo, et al.
Published: (2021-01-01) -
Hemoadsorption in Multiorgan Failure Due to Viscerocutaneous Loxoscelism
by: Raúl Valenzuela Córdova, et al.
Published: (2025-01-01)